CSL Seqirus' cell-based influenza vaccine, FLUCELVAX QUAD, will be available on the National Immunisation Program for the 2024 Australian influenza season.
CSL Seqirus confirms availability of cell-based flu vaccine for 2024 season
February 1, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Please stop falling this ridiculous trap, intentional or otherwise, it is not good
November 27, 2025 - - Latest News -
MSD to bring vaccine distribution back in-house after 40-year partnership with CSL Seqirus
November 27, 2025 - - Latest News -
Pharmac announces 90-day dispensed quantities of HIV medicines
November 27, 2025 - - Latest News -
Landmark report warns Australia’s hospital pharmacy system is at an 'inflection point'
November 27, 2025 - - Latest News -
Australia releases first national estimate of women living with metastatic breast cancer
November 27, 2025 - - Latest News -
Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours
November 27, 2025 - - Australian Biotech -
Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership
November 27, 2025 - - Latest News
